Your Current Location : Fund Card : Portfolio Classification |
|
|
|
ICICI Pru Nifty Pharma Index Fund Reg (G) |
[Equity: Sectoral] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
-1.51 |
Equity |
99.87 |
Trep |
1.64 |
|
|
Concentration Analysis |
Top 5 Holdings |
63.06% |
Top 10 Holdings |
81.65% |
Top 25 Holdings |
100.00% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
99.87 |
Cash |
0.13 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
5.38 |
PE Ratio |
38.37 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
26.82 |
Cipla Limited |
12.04 |
Dr Reddys Laboratories Limited |
11.49 |
DIVI LABORATORIES LTD |
6.73 |
Lupin Limited |
5.98 |
Aurobindo Pharma Limited |
4.69 |
Zydus Lifesciences Limited |
3.91 |
Alkem Laboratories Limited |
3.80 |
Torrent Pharmaceuticals Limited |
3.64 |
IPCA Laboratories Limited |
2.55 |
MANKIND PHARMA LIMITED |
2.54 |
Laurus Labs Limited |
2.37 |
Glenmark Pharmaceuticals Limited |
2.20 |
Abbott India Limited |
2.20 |
Gland Pharma Limited |
1.96 |
J B Chemicals and Pharma Limited |
1.81 |
Biocon Limited |
1.80 |
TREPS |
1.64 |
Natco Pharma Limited |
1.33 |
Sanofi India Limited |
1.12 |
Granules India Limited |
0.89 |
Net Current Assets |
-1.51 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
|
|
|
|
|